story of the week
Trastuzumab Deruxtecan Is Effective in Previously Treated HER2+ Breast Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The New England Journal of Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Trastuzumab Deruxtecan in Previously Treated HER2-Positive Breast Cancer
N. Engl. J. Med 2019 Dec 11;[EPub Ahead of Print], S Modi, C Saura, T Yamashita, YH Park, SB Kim, K Tamura, F Andre, H Iwata, Y Ito, J Tsurutani, J Sohn, N Denduluri, C Perrin, K Aogi, E Tokunaga, SA Im, KS Lee, SA Hurvitz, J Cortes, C Lee, S Chen, L Zhang, J Shahidi, A Yver, I KropFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.